3-heteroaryl pyrrolidine and piperidine orexin receptor agonists
US-12552767-B2 · Feb 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Yang Dexi patents
Yang Dexi is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Yang Dexi |
| Total patents | 32 |
| First publication | Nov 17, 2016 |
| Latest publication | Feb 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Cyclopentapyrrole orexin receptor agonists
US-12497362-B2 · Dec 16, 2025 · US
Factor XI activation inhibitors
US-12492187-B2 · Dec 9, 2025 · US
Factor XI activation inhibitors
US-12428397-B2 · Sep 30, 2025 · US
Pyrrolidine orexin receptor agonists
US-12331018-B2 · Jun 17, 2025 · US
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
US-12312332-B2 · May 27, 2025 · US
Factor XI activation inhibitors
US-12304899-B2 · May 20, 2025 · US
3-amino pyrrolidine and piperidine macrocyclic orexin receptor agonists
US-2024002397-A1 · Jan 4, 2024 · US
3-heteroaryl pyrrolidine and piperidine orexin receptor agonists
US-2024002359-A1 · Jan 4, 2024 · US
Bicycloheptane pyrrolidine orexin receptor agonists
US-2023365533-A1 · Nov 16, 2023 · US
Recent patents
Latest publications not already listed above.
Cyclopentapyrrole orexin receptor agonists
US-2023257348-A1 · Aug 17, 2023 · US
Bicycloheptane pyrrolidine orexin receptor agonists
US-11680060-B2 · Jun 20, 2023 · US
Factor xi activation inhibitors
US-2023167085-A1 · Jun 1, 2023 · US
Factor xi activation inhibitors
US-2023147170-A1 · May 11, 2023 · US
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
US-2023018413-A1 · Jan 19, 2023 · US
Factor xi activation inhibitors
US-2022235033-A1 · Jul 28, 2022 · US
Pyrrolidine orexin receptor agonists
US-2022144771-A1 · May 12, 2022 · US
Bicycloheptane pyrrolidine orexin receptor agonists
US-2022056017-A1 · Feb 24, 2022 · US
Metallo-beta-lactamase inhibitors and methods of use thereof
US-11207312-B2 · Dec 28, 2021 · US
5-alkyl pyrrolidine orexin receptor agonists
US-11098029-B2 · Aug 24, 2021 · US
Metallo-beta-lactamase inhibitors and methods of use thereof
US-2020375987-A1 · Dec 3, 2020 · US
Metallo-Beta-Lactamase Inhibitors and Methods of Use Thereof
US-2020281913-A1 · Sep 10, 2020 · US
5-alkyl pyrrolidine orexin receptor agonists
US-2020255403-A1 · Aug 13, 2020 · US
Metallo-beta-lactamase inhibitors
US-10544130-B2 · Jan 28, 2020 · US
Metallo-beta-lactamase inhibitors
US-2019144432-A1 · May 16, 2019 · US
Metallo-β-lactamase inhibitors
US-10227331-B2 · Mar 12, 2019 · US
Metallo-beta-lactamase inhibitors
US-10221163-B2 · Mar 5, 2019 · US
Metallo-beta-lactamase inhibitors
US-2018244656-A1 · Aug 30, 2018 · US
Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
US-9839642-B2 · Dec 12, 2017 · US
Metallo-beta-lactamase inhibitors
US-9708336-B2 · Jul 18, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merck Sharp & Dohme | 19 |
| Merck Sharp & Dohme Llc | 14 |
| Yang Dexi | 4 |
| Wei Lan | 3 |
| Bogen Stephane L | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/14 | 23 |
| C07D405/14 | 16 |
| C07D417/14 | 15 |
| C07D413/14 | 15 |
| C07D471/04 | 14 |